The EPMA journal
Journal
Overview
publication venue for
-
Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021..
12.
2021
-
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine.
2023
-
Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine.
2022
-
Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
2022
-
Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.
2022
-
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person.
2021
-
Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.
2021
-
Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks.
2021
-
The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.
2021
-
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles.
2021
-
Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine.
2021
-
Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism.
2020
-
Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine.
2020
-
Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.
2018
-
Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine.
2014
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)